Precision boosts
the future.
Our intelligently designed systems empower surgeons to perform surgeries with unparalleled precision and elegance.
Our intelligently designed systems empower surgeons to perform surgeries with unparalleled precision and elegance.
The exclusive Chinese startup to win the MassRobotics Healthcare Robotics Catalyst Program, we've secured our place as innovators on the global stage.
Successful seed and pre-A funding rounds in 2021 and 2023, Maestro Surgical is dedicated to advancing surgical technology and reshaping the future of healthcare.
Incubated and seed funded by Panacea Venture.
Co-founder of Panacea Venture, Partner at KPCB (China) and DT Capital, Venture Partner at SB China Venture Capital. Formerly Vice President at WuXi Apptec, Independent Director and Audit Committee Chairman at Chemspec International; research scientist and business manager at Pfizer. PhD in Chemistry from New York University, MBA from the Booth School of Business at the University of Chicago, and BS from Fudan University.
Renowned Professor and Chief Physician at Huashan Hospital, affiliated with Fudan University. A leading figure in Spinal Surgery, also serving as a Doctoral Supervisor. Accomplished roles include Chairman of the Orthopedics Branch at the Shanghai Medical Association and Vice President of the Orthopedics Branch at the Chinese Medical Doctor Association. Noteworthy achievements encompass over 10 national and provincial research projects, 250+ academic papers (100+ indexed by SCI), and leadership roles in numerous industry associations. Graduated from Shanghai Medical University in 1985.